These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29444979)

  • 21. Effect of selenium on thioredoxin reductase activity in Txnrd1 or Txnrd2 hemizygous mice.
    Kiermayer C; Michalke B; Schmidt J; Brielmeier M
    Biol Chem; 2007 Oct; 388(10):1091-7. PubMed ID: 17937623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of thioredoxin reductase 1 correlates with platinum-based chemotherapeutic induced tissue injury.
    Cheng P; Liu H; Li Y; Pi P; Jiang Y; Zang S; Li X; Fu A; Ren X; Xu J; Holmgren A; Lu J
    Biochem Pharmacol; 2020 May; 175():113873. PubMed ID: 32092292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation.
    Mandal PK; Schneider M; Kölle P; Kuhlencordt P; Förster H; Beck H; Bornkamm GW; Conrad M
    Cancer Res; 2010 Nov; 70(22):9505-14. PubMed ID: 21045148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. To inhibit TrxR1 is to inactivate STAT3-Inhibition of TrxR1 enzymatic function by STAT3 small molecule inhibitors.
    Busker S; Page B; Arnér ESJ
    Redox Biol; 2020 Sep; 36():101646. PubMed ID: 32863208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of thioredoxin reductase 1 by porphyrins and other small molecules identified by a high-throughput screening assay.
    Prast-Nielsen S; Dexheimer TS; Schultz L; Stafford WC; Cheng Q; Xu J; Jadhav A; Arnér ES; Simeonov A
    Free Radic Biol Med; 2011 May; 50(9):1114-23. PubMed ID: 21262347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells.
    Chepikova OE; Malin D; Strekalova E; Lukasheva EV; Zamyatnin AA; Cryns VL
    Breast Cancer Res Treat; 2020 Oct; 183(3):549-564. PubMed ID: 32696316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Inflammatory Effect of Dimethyl Fumarate Associates with the Inhibition of Thioredoxin Reductase 1 in RAW 264.7 Cells.
    Yang R; Sun S; Guo Y; Meng Y; Liu H; Shi M; Guan S; Xu J
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The production of reactive oxygen species enhanced with the reduction of menadione by active thioredoxin reductase.
    Li J; Zuo X; Cheng P; Ren X; Sun S; Xu J; Holmgren A; Lu J
    Metallomics; 2019 Sep; 11(9):1490-1497. PubMed ID: 31359011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sec-containing TrxR1 is essential for self-sufficiency of cells by control of glucose-derived H2O2.
    Peng X; Mandal PK; Kaminskyy VO; Lindqvist A; Conrad M; Arnér ES
    Cell Death Dis; 2014 May; 5(5):e1235. PubMed ID: 24853413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic cooperation between auranofin, a thioredoxin reductase inhibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer.
    Raninga PV; Lee AC; Sinha D; Shih YY; Mittal D; Makhale A; Bain AL; Nanayakarra D; Tonissen KF; Kalimutho M; Khanna KK
    Int J Cancer; 2020 Jan; 146(1):123-136. PubMed ID: 31090219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of thioredoxin reductase 1 protects mice from acute acetaminophen-induced hepatotoxicity through enhanced NRF2 activity.
    Patterson AD; Carlson BA; Li F; Bonzo JA; Yoo MH; Krausz KW; Conrad M; Chen C; Gonzalez FJ; Hatfield DL
    Chem Res Toxicol; 2013 Jul; 26(7):1088-96. PubMed ID: 23697945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperlongumine Inhibits Thioredoxin Reductase 1 by Targeting Selenocysteine Residues and Sensitizes Cancer Cells to Erastin.
    Yang Y; Sun S; Xu W; Zhang Y; Yang R; Ma K; Zhang J; Xu J
    Antioxidants (Basel); 2022 Apr; 11(4):. PubMed ID: 35453395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H
    Dagnell M; Pace PE; Cheng Q; Frijhoff J; Östman A; Arnér ESJ; Hampton MB; Winterbourn CC
    J Biol Chem; 2017 Sep; 292(35):14371-14380. PubMed ID: 28684416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzophenanthridine Alkaloid Chelerythrine Elicits Necroptosis of Gastric Cancer Cells via Selective Conjugation at the Redox Hyperreactive C-Terminal Sec
    Liu M; Sun S; Meng Y; Wang L; Liu H; Shi W; Zhang Q; Xu W; Sun B; Xu J
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thioredoxin 1 mediates TGF-β-induced epithelial-mesenchymal transition in salivary adenoid cystic carcinoma.
    Jiang Y; Feng X; Zheng L; Li SL; Ge XY; Zhang JG
    Oncotarget; 2015 Sep; 6(28):25506-19. PubMed ID: 26325518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elovanoid-N34 modulates TXNRD1 key in protection against oxidative stress-related diseases.
    Calandria JM; Bhattacharjee S; Kala-Bhattacharjee S; Mukherjee PK; Feng Y; Vowinckel J; Treiber T; Bazan NG
    Cell Death Dis; 2023 Dec; 14(12):819. PubMed ID: 38086796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
    Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
    Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Thioredoxin/Thioredoxin Reductase Induces Synthetic Lethality in Lung Cancers with Compromised Glutathione Homeostasis.
    Yan X; Zhang X; Wang L; Zhang R; Pu X; Wu S; Li L; Tong P; Wang J; Meng QH; Jensen VB; Girard L; Minna JD; Roth JA; Swisher SG; Heymach JV; Fang B
    Cancer Res; 2019 Jan; 79(1):125-132. PubMed ID: 30401714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further exploration of DVD-445 as a lead thioredoxin reductase (TrxR) inhibitor for cancer therapy: Optimization of potency and evaluation of anticancer potential.
    Jovanović M; Zhukovsky D; Podolski-Renić A; Žalubovskis R; Dar'in D; Sharoyko V; Tennikova T; Pešić M; Krasavin M
    Eur J Med Chem; 2020 Apr; 191():112119. PubMed ID: 32087464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jolkinolide B targets thioredoxin and glutathione systems to induce ROS-mediated paraptosis and apoptosis in bladder cancer cells.
    Sang J; Li W; Diao HJ; Fan RZ; Huang JL; Gan L; Zou MF; Tang GH; Yin S
    Cancer Lett; 2021 Jul; 509():13-25. PubMed ID: 33836250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.